Eating flaxseed may not ease menopausal hot flashes after all, despite some promising early evidence that it might, according to a U.S. study.
Researchers at the Mayo Clinic in Rochester, Minnesota found that 188 women who were randomly assigned to eat a daily flaxseed bar saw no more improvement in their hot flashes than women given flax-free "placebo" bars.
Over six weeks, more than one-third of the women in each group had a 50 percent reduction in the frequency and severity of their hot flashes.
The similar results in both groups suggest a placebo effect or some other explanation for the changes some women reported, said researchers led by Debra Barton, whose findings were reported in the journal Menopause.
"What women should take from this study is that there is little compelling information to try flaxseed if the objective is to reduce hot flashes," Barton told Reuters Health in an email.
In an earlier pilot study, Barton and her colleagues had found that women who consumed flaxseed did see their hot flashes wane, on average.
But that study had no comparison group of women taking a placebo, she noted.
Flaxseed is high in compounds called lignans, a type of phytoestrogen. These are plant chemicals structurally similar to estrogen that may have a weak estrogen-like, and an anti-estrogen, effect on the body.
The most effective treatment for hot flashes is hormone replacement therapy, but since hormones have been linked to increased risks of heart disease, blood clots and breast cancer, many women want alternate remedies.
Some anti-depressants have been found to cool hot flashes by as much as 80 percent. But Burton noted that "natural" products, such as black cohosh, soy and now flaxseed, have failed to stand up to clinical trials.
The latest study included women with bothersome hot flashes, such as those occurring at least an average of four times a day. Half of them had a history of breast cancer, which would generally make it inadvisable to treat the symptoms with hormones.
Barton's team randomly assigned the women to eat either a flaxseed bar or a placebo bar each day for six weeks. The flaxseed bar contained fiber, protein and 410 milligrams of lignans. The placebo bar provided fiber and protein.
By the end of the study, 36 percent of women in both groups had a 50 percent drop in their hot flash "scores", which rank symptoms and severity. One third of women in each group said they thought their symptoms were moderately to "very much" improved.
Barton said there were several possible reasons.
In general, hot flash studies have found a significant placebo effect, with women feeling better because they expect to. Overall, 20 percent to 30 percent of placebo users improve, though some studies find even higher rates.
On top of that, hot flashes naturally cool off over time for some women, and they can be extremely variable since environmental triggers, such as hot weather or stress, often set them off.
"This is why it's important to perform randomized, placebo-controlled trials to understand the potential risks and benefits of interventions," she said. SOURCE: http://bit.ly/o9DEa5
Solar and wind's share in electricity production from renewable sources rose globally, share of hydro dropped in 2013, according to International Energy Agency report.
The fragile reef, which stretches 2,300 km (1,430 miles) along Australia's east coast was the centrepiece of a campaign by green groups and tour operators opposing the plan
World Bank President Jim Yong Kim said Western healthcare facilities would easily be able to contain the disease, and urged wealthy nations to share the knowledge and resources to help African countries tackle it.
Saudi Deputy Labor Minister Mufraj bin Saad al-Haqbani said the decision was temporary.
The World Health Organization has announced that the Ebola virus has killed some 1,552 people in West Africa, mostly in Liberia, Guinea and Sierra Leone, since the outbreak began in January.
UN deputy secretary general Jan Eliasson said the failure to address the issue of sanitation would prove “disastrous.”
The Ebola outbreak in West Africa has taken 1,552 lives out of 3,069 known cases in four countries and "continues to accelerate", WHO said
Presidential Press Secretary Jerolinmek Piah told AA the names would be announced later.
The WHO urged a range of "regulatory options", including prohibiting e-cigarette makers from making health claims
The doctor died after receiving the experimental drug ZMapp.
Japan has received inquiries from some countries on the influenza drug favipiravir, or T-705 as it is known in the developmental code.
Some 54 people have died in or near the capital Accra, and around 300 people are now being infected daily with the highly contagious disease, putting pressure on local health facilities, said Linda Van-Otoo, GHS director for Greater Accra.
A Philippine seaman is being monitored in Togo for signs of the disease but authorities say the country is still Ebola-free, despite dozens of workers returning from Liberia.
A 36-year-old man from Senegal is being tested in Barcelona.
MSF (Doctors Without Borders) has deployed 1,000 of its own staff in the stricken region, running centres that currently have 300 beds
On Wednesday, the residents of the two communities woke up just after the president ordered the quarantine only to find their community barricaded with soldiers and police officers preventing people from leaving or entering the two areas.